🇺🇸 FDA
Pipeline program

SEMAGLUTIDE, SEMAGLUTIDE, INSULIN GLARGINE, DAPAGLIFLOZIN

BioPhenoT2D

Approved small_molecule active

Quick answer

SEMAGLUTIDE, SEMAGLUTIDE, INSULIN GLARGINE, DAPAGLIFLOZIN for type 2 diabetes is a Approved program (small_molecule) at Fondazione Telethon ETS with 1 ClinicalTrials.gov record(s).

Program details

Company
Fondazione Telethon ETS
Indication
type 2 diabetes
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials